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Abstract
Background: The aim of this study was to establish a score system derived from clinical, 
echocardiographic and electrocardiographic indexes and evaluate its clinical value for cardiac 
resynchronization therapy (CRT) patient selection.
Methods: Ninety-three patients receiving CRT were enrolled. A patient selection score system 
was generated by the clinical, echocardiographic and electrocardiographic parameters achiev-
ing a significant level by univariate and multivariate Cox regression model. The positive re-
sponse to CRT was a left ventricular end systolic volume decrease of ≥ 15% and not reaching 
primary clinical endpoint (death or re-hospitalization for heart failure) at the end of follow-up.
Results: Thirty-nine patients were CRT non-responders (41.94%) and 54 were responders 
(58.06%). A 4-point score system was generated based on tricuspid annular plane systolic ex-
cursion (TAPSE), longitudinal strain (LS), and complete left bundle branch block (CLBBB) 
combined with a wide QRS duration (QRSd). The sensitivity and specificity for prediction of 
a positive response to CRT at a score > 2 were 0.823 and 0.850, respectively (AUC: 0.92295% 
CI 0.691–0.916, p< 0.001).
Conclusions: A patient selection score system based on the integration of TAPSE, LS and 
CLBBB combined with a wide QRSd can help to predict positive response to CRT effectively 
and reliably. (Cardiol J 2015; 22, 2: 179–187)
Key words: two-dimensional speckle tracking echocardiography, real-time 
three-dimensional echocardiography, cardiac resynchronization therapy
Introduction
Cardiac resynchronization therapy (CRT) of-
fers proven benefit to patients with heart failure 
of wide QRS duration (QRSd). Although several 
large randomized clinical trials have demonstrated 
improved symptoms, reduced hospital admissions 
and prolonged survival, up to 30% of these carefully 
selected patients do not benefit from this invasive 
and costly intervention [1, 2].
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Correcting mechanical dyssynchrony within the 
left ventricular (LV) was proposed as one of the key 
mechanisms of benefit from CRT [3, 4]. However, 
the PROSPECT trial demonstrated that no single 
echocardiographic measurement of dyssynchrony 
may be recommended to improve patient selection 
for CRT [5]. It was one of the reasons that many 
clinical, electrocardiographic and echocardiographic 
features may affect CRT response.
The purpose of this study was to evaluate 
whether a score system integrating clinical, elec-
trocardiographic and echocardiographic factors 
could help to predict CRT response.
Methods
Study population
A total of 106 dilated cardiomyopathy patients 
who received CRT in Zhongshan Hospital and Renji 
Hospital were enrolled in this study between Oc-
tober 2010 and September 2013. Exclusion criteria 
were: (1) the presence of atrial fibrillation or irregu-
lar heart rhythm, (2) poor echocardiographic image. 
All subjects gave their informed consent, and the 
local Ethics Committee approved the protocol.
CRT device implantation
The criteria for CRT implantation were: (1) LV 
ejection fraction (LVEF) ≤ 35%, (2) QRSd ≥ 120 ms 
and (3) New York Heart Association (NYHA) 
functional class III or IV despite optimal pharma-
cological therapy. The right atrial and right ven-
tricular (RV) leads were positioned at right atrial 
appendage and RV apex. The LV pacing lead was 
inserted in a lateral or postero-lateral vein. AV and 
VV delays were optimized under echocardiography 
after implantation to maximize aortic velocity time 
integral. Patients were regularly followed up at 
6 months interval or when symptoms deteriorated. 
All patients’ histories, medications, assessments 
of heart failure, electrocardiogram (ECG) and 
echocardio graphy were obtained before CRT im-
plantation and during regular follow-up.
Electrocardiogram
Patients underwent 12-lead ECG at a paper 
speed of 25 mm/s at baseline and during follow-
up. The QRSd was measured using the widest 
QRS complex in leads II, V1 and V6. Data from at 
least 3 distinct cardiac cycles were averaged. QRS 
morphology was defined as complete left bundle 
branch block (CLBBB) or non-CLBBB. Experi-
enced observers who were blind to all other patient 
data interpreted the ECG data.
Clinical assessment
An independent physician blinded to all other 
data performed the clinical evaluation. The assign-
ment to ischemic etiology was based on clinical 
history of prior myocardial infarction, prior per-
cutaneous coronary intervention, prior coronary 
artery bypass surgery, or the angiographic finding 
of > 70% stenosis of at least one major coronary 
artery, similar to the assignment used in previous 
studies [6]. The primary endpoint was unplanned 
hospitalization for a major cardiovascular event 
or death from any cause. A positive response to 
CRT was defined as a decrease in LV end diastolic 
volume ≥ 15% at the end of follow-up compared 
with baseline and not reach the primary endpoint 
at the end of follow-up after CRT.
Echocardiographic imaging
Images were obtained in the left lateral decu-
bitus position with a commercially available system 
(iE33, Philips Medical Systems, N.A., Bothell, 
WA, USA) equipped with S5-1 and X3. Standard 
two-dimensional (2D) images were acquired ac-
cording to recommendations of the American 
Society of Echocardiography [7]. For acquisitions 
of a full-volume data set of real-time 3-dimensional 
echocardiography (RT3DE), 4 smaller real-time 
volumes were combined to provide a larger py-
ramidal volume, during breath hold and required 
a relatively stable R-R interval to minimize transla-
tion artifacts between the 4 acquired subvolumes. 
Depth was minimized to optimize the frame rate. 
At least 3 beats for 2D images were digitally stored 
for offline analysis. In this study, a frame rate of 
53 to 72 FPS (frame rate per second) for speckle 
tracking analysis and 19 to 34 FPS for RT3DE 
analysis were used.
Conventional echocardiographic  
indexes analysis
Each measurement was taken from the aver-
age of 3 continuous cardiac cycles. The severity 
of mitral regurgitation (MR) and tricuspid regur-
gitation (TR) were analyzed and categorized into 
3 grades: mild, moderate and severe by the color 
flow jet area, as recommended by the American 
Society of Echocardiography [8]. RV and LV pre-
ejection delay was determined as the time from 
the QRS onset to the onset of pulsed Doppler flow 
in the LV and RV outflow tracts. Interventricular 
mechanical delay (IVMD) was calculated as the 
difference in LV and RV pre-ejection delay. Tri-
cuspid annular plane systolic excursion (TAPSE) 
was acquired by placing an M-mode cursor through 
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the tricuspid annulus and measuring the amount of 
longitudinal motion of the annulus at peak systole. 
Systolic pulmonary artery pressure (SPAP) was 
determined from peak TR jet velocity, using the 
simplified Bernoulli equation and combined this 
value with an estimate of the right atrial pressure.
Speckle tracking-derived  
strain value analysis
QLAB version 8.1 (Philips Medical System, 
N.A., Bothell, WA, USA) was used for strain and 
LVEF analysis. The automatic tracking analysis 
was performed in the apical 4-chamber, 2-chamber, 
apical LV longitudinal view for longitudinal strain 
(LS) and in the parasternal short-axis view at ba-
sal and mid-papillary level for circumferential and 
radial strain (RS) according to the vendor’s instruc-
tions. The endocardial border was manually traced 
at end-diastole. Tracking was then performed and 
the strain-time curves were obtained automatically. 
The strain-time curves were analyzed manually, 
and if tracking was suboptimal, the endocardial bor-
der was retraced. If satisfactory tracking was not 
accomplished within 3 attempts, the non-tracking 
segments were excluded from analysis.
Peak LS measurements were obtained from 
the basal, mid-segments of the anterior, inferior, an-
teroseptal, anterolateral, inferoseptal, inferolateral 
walls, apical segments of anterior, inferior, septal, 
lateral walls and apex, 17 segments in total. Peak 
circumferential strain (CS) and RS measurements 
were obtained from the basal, mid-segments of the 
anterior, inferior, anteroseptal, anterolateral, infer-
oseptal, inferolateral walls, 12 segments in total. 
Regional strain values were averaged to determine 
global LS/CS/RS.
Standard deviations of the time to negative 
peak value of LS for 17 segments (LS-SD), of the 
time to negative peak value of CS for 12 segments 
(CS-SD) and of the time to positive peak value of RS 
for 12 segments (RS-SD) were calculated to evalu-
ate LV dyssynchrony. LS-SD, CS-SD and RS-SD 
were expressed as percentages of the duration of 
the cardiac cycle.
RT3DE-derived LVEF analysis and  
systolic dyssynchronization index
Five reference points were set by the user 
at the end-diastolic and the end-systolic frames 
separately: the septal, lateral mitral annulus at 
apical 4-chamber view; anterior, inferior mitral 
annulus at apical 2-chamber view and the apex 
(from either one of the views). Then the software 
automatically delineated the LV endocardial border 
and created a mathematical model that represented 
the LV cavity. After detection of the endocardium 
borders, the user can correct the shape of the LV 
reference at the end-diastolic or end-systolic ref-
erence frame. The intraventricular dyssynchrony 
of LV was evaluated by the standard deviation of 
the time to reach minimum regional volume for 
16 segments, defining the systolic dyssynchronization 
index (SDI) as described by Kapetanakis et al. [9].
Statistical analysis
Continuous variables were expressed as the 
mean ± standard deviation. Nominal variables 
were expressed as percentages. Differences be-
tween beseline and follow-up were determined 
using one-way ANOVA test for continuous vari-
ables and Kruskal-Wallis test for categorical data. 
The baseline variables analyzed were: (1) age, 
(2) gender, (3) hypertension, (4) diabetes mel-
litus, (5) etiology of heart failure (ischemic or 
non-ischemic), (6) NYHA class, (7) clearance of 
creatinine calculated by Cockcroft-Gault equation, 
(8) CLBBB combined with QRSd ≥ 150 ms, (9) left 
ventricular end diastolic diameter (LVEDD), 
(10) left ventricular end systolic diameter (LVESD), 
(11) left ventricular end diastolic volume (LVEDV), 
(12) left ventricular end systolic volume (LVESV), 
(13) LVEF, (14) degree of MR, (15) degree of TR, 
(16) SPAP, (17) TAPSE, (18) IVMD, (19) SDI, 
(20) LS, (21) CS, (22) RS, (23) LS-SD, (24) CS-SD, 
and (25) RS-SD. Possible predictors of CRT response 
were determined by univariate Cox regression. 
Variables that achieved a significant level of p < 0.1 
were selected for evaluation by a multivariate Cox 
regression model. Score system was generated by 
the variables with a significant level of p ≤ 0.05 by 
multivariate Cox regression. The Wald test was 
used to evaluate the weight of the variables to 
predict CRT response. We assigned 2 points for 
the variable with the highest value of Wald. Higher 
scores reflected a greater likelihood to respond to 
CRT. A receiver operating characteristic curve 
(ROC) was obtained and the optimal value with the 
greatest total of sensitivity and specificity in the 
prediction of CRT response was selected. Kaplan-
Meier plots were performed for each parameter 
used. Data were analyzed by SPSS version 16.0 
(SPSS, Inc, Chicago, IL, USA). A value of p ≤ 0.05 
was considered significant.
Results
One patient was not implanted with CRT suc-
cessfully because of coronary sinus anatomy. Six 
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patients were lost during follow-up. After exclusion 
of 3 patients due to poor image and 3 due to atrial 
fibrillation, the remaining 93 patients formed the 
final study group. The baseline characteristics of 
the study population were listed in Table 1. Optimal 
medical therapy for heart failure was given to all 
patients prior to and after CRT implantation. The 
follow-up duration was 20.1 ± 10.7 months, rang-
ing from 3 to 42 months. The following primary 
endpoints of cardiovascular events occurred in 
20 (21.51%) patients: 16 (17.20%) deaths from wors-
ening heart failure and 4 (4.44%) hospitalizations for 
deteriorating heart failure. The follow-up duration 
was 6.8 ± 4.6 months, ranging from 4 to 21 months 
for those deaths. A total of 39 (41.94%) patients were 
non-responders and 54 (58.06%) were responders.
Changes of echocardiographic values
At the end of follow-up, in all patients, QRS dura-
tion decreased from 167.25 ± 30.94 ms to 142.00 ± 
± 23.21 ms (p = 0.000). LVEDV and LVESV de-
creased significantly, which resulted in an increase 
of LVEF at follow-up. A significant improvement of 
intra- and inter-ventricular dyssynchrony was dem-
onstrated. SPAP improved from 44.29 ± 17.39 mm 
Hg to 36.61 ± 15.18 mm Hg (p = 0.000). However, 
all these values showed no significant improvement 
in non-responders. In all patients, no difference of 
LS, CS, RS and TAPSE was observed after CRT 
improvement. However, in responders, LS showed 
the tendency of improvement (from –8.52 ± 2.10% 
to –9.09 ± 2.96%, p = 0.051) at the mid-term of 
follow-up, and improved significantly at the end of 
follow-up (to –9.54 ± 3.64%, p = 0.017) (Table 2).
Predictors of CRT response
The variables of CLBBB combined with a wide 
QRSd, TAPSE, SDI, LS and CS achieved a signifi-
cant level of p < 0.1 by univariate Cox regression 
when dependent variable was a positive response 
to CRT (Table 3). However, in multivariate Cox 
regression analysis, only TAPSE remained sig-
nificant in predicting CRT response (HR: 1.095, 
Wald value: 7.570, p = 0.006, 95% CI: 1.026–1.168) 
(Table 3). Table 4 listed the results of univariate 
Cox regression with 4 variables with a p < 0.1 when 
the dependent variable was mortality. In multivari-
ate Cox regression analysis, LS (HR: 1.398, Wald 
value: 5.355, p = 0.006, 95% CI: 1.053–1.858) and 
CLBBB with a wide QRSd (HR: 5.360, Wald value: 
4.161, p = 0.041, 95% CI: 0.037–0.936) achieved 
a significant level. The cutoff points for TAPSE 
and LS to predict positive response of CRT were 
calculated from ROC curves (Table 5, Fig. 1).
A 4-point score was generated based on the 
variable significant by multivariate Cox regression 
when the dependent variable was response to CRT 
and on the 2 variables significant when the depend-
ent variable was death. We assigned 1 point each 
for CLBBB combined with a wide QRSd, and LS ≤ 
–7.22%, and 2 points for TAPSE ≥ 14.8 mm.
The overall mean score was 2.38 ± 1.19. The 
mean score was 3.08 ± 0.85 in responders, 1.44 ± 
± 0.91 in non-responders and 0.81 ± 0.98 in 
deaths. The cutoff point for score system was 
> 2 by ROC analysis (Fig. 2). CRT responders, 
non-responders and deaths with a score > 2 were 
50/54 (92.59%), 11/39 (28.21%) and 4/16 (25.00%), 
respectively (Table 6). The score system was 
Table 1. Baseline characteristics of patients.
All patients Responders Non-responders Deaths
N 93 54 39 16
Age [years] 60.8 ± 12.7 60.8 ± 12.2 60.7 ± 13.5 66.0 ± 14.2
Male 66 (70.97%) 31 (57.41%) 28 (71.79%) 11 (68.75%)
Hypertension 33 (35.48%) 24 (44.44%) 9 (23.08%) 5 (31.25%)
Diabetes mellitus 15 (16.13%) 13 (24.07%) 2 (5.13%) 1 (6.25%)
Valvular disease 2 (2.15%) 1 (1.85%) 1 (2.56%) 0 (0.00%)
Ischemic cardiomyopathy 16 (17.20%) 9 (16.67%) 7 (17.95%) 4 (25.00%)
CLBBB 42 (45.16%) 33 (61.11%) 9 (23.08%) 5 (31.25)
ACEI/ARB 80 (86.02%) 47 (87.04%) 33 (84.62%) 14 (87.50%)
Beta-blocker 83 (89.25%) 51 (94.44%) 32 (82.05%) 14 (87.50%)
Loop diuretics 74 (79.57%) 47 (87.04%) 27 (69.23%) 13 (81.25%)
Spironolactone 67 (72.04%) 42 (77.78%) 25 (64.10%) 14 (87.50%)
Digoxin 47 (50.54%) 28 (51.85%) 19 (48.72%) 11 (68.75%)
ACEI — angiotensin-converting enzyme inhibitor; ARB — angiotensin receptor blocker; CLBBB — complete left bundle branch block
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Table 3. Univariate Cox regression for variables related to cardiac resynchronization therapy response.
Variables Hazard ratios Wald value P 95% CI
CLBBB with a wide QRSd 2.555 5.273 0.022 1.147–5.690
Longitudinal strain 0.861 5.191 0.023 0.756–0.979
Circumferential strain 1.123 3.761 0.052 0.999–1.264
TAPSE 1.087 6.711 0.010 1.020–1.157
SDI 1.016 5.289 0.021 1.002–1.029
CI — confidential interval; CLBBB — complete left bundle branch block; QRSd — QRS duration; TAPSE — tricuspid annular plane systolic excursion; 
SDI — systolic dyssynchronization index
Table 4. Univariate Cox regression for variables related to deaths.
Variables Hazard ratios Wald value P 95% CI
TAPSE 0.749 10.178 0.001 0.628–0.895
Mitral regurgitation 2.079 4.110 0.043 1.025–4.219
Longitudinal strain 1.549 11.881 0.001 1.208–1.986
CLBBB with a wide QRSd 0.088 10.269 0.001 0.020–0.390 
CI — confidential interval; CLBBB — complete left bundle branch block; QRSd — QRS duration; TAPSE — tricuspid annular plane systolic excursion
Table 5. Cutoff point, sensitivity and specificity of tricuspid annular plane systolic excursion (TAPSE), 
dyssynchronization index, longitudinal strain (LS) and QRS duration (QRSd).
AUC P Cut-off point Sensitivity Specificity 95% CI
TAPSE 0.840 0.000 ≥ 14.8 mm 0.880 0.722 0.744–0.912
CLBBB with wide QRSd 0.837 0.000 – 0.868 0.821 0.740–0.909
LS 0.785 0.000 ≤ –7.22% 0.804 0.737 0.681–0.818
AUC — area under curve; CI — confidential interval; CLBBB — complete left bundle branch block
Figure 2. Receiver operating characteristic curve for 
score system in the prediction of cardiac resynchroni-
zation therapy response (cutoff point: > 2; AUC: 0.922; 
sensitivity: 0.823; specificity: 0.850; p < 0.001; 95% 
CI: 0.691–0.916).
Figure 1. Receiver operating characteristic curves for 
3 variables in the prediction of cardiac resynchroniza-
tion therapy response; CLBBB — complete left bundle 
branch block; LS — longitudinal strain; TAPSE — tricus-
pid annular plane systolic excursion.
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associated with CRT response (HR: 5.69, p = 0.000, 
95% CI: 2.96–10.68) by Cox regression.
Discussion
Our study demonstrated that CLBBB com-
bined with a wide QRSd, TAPSE and LS was related 
to CRT response. This score system could help 
to select patients with a higher likelihood of CRT 
response.
The PROSPECT trial negated the role of 
a single echocardiographic measurement of dys-
synchrony in patient selection for CRT [5]. The 
EchoCRT trial also concluded that mechanical dys-
synchrony assessed by tissue Doppler imaging and 
speckle tracking radial strain was not the primary 
determinant of response to CRT [10]. Furthermore, 
the use of CRT did not reduce the rate of death from 
any cause or first hospitalization for heart failure 
among patients with a duration of less than 130 ms. 
Similarly, in our study, parameters of mechanical 
dyssynchrony did not help to predict response of 
CRT. However, CLBBB with a wide QRSd was 
a predictor of responder of CRT.
One of the key mechanisms of benefit from 
CRT is to correct mechanical dyssynchrony [3, 4]. 
However, in order to restore mechanical dys-
synchrony, dyssynchronous segments must be 
viable in order to recruit their “wasted work” to-
ward cardiac output. Patients with significant scar 
burden may not respond to CRT because myocar-
dial segments are scarred and thus lack residual 
contractility that can be recruited by CRT [11]. In 
those with severe LV dysfunction, the percent of 
patients with detectable scar by Cardiac magnetic 
resonance (CMR) imaging ranged 12–100%, de-
pending on the underlying cause of heart failure 
[12]. Both White et al. [13] and Ypenburg et al. 
[14] reported that total scar burden, determined 
by CMR is linearly related to relative changes in 
LVESV after 6 months of CRT, thus the greater 
amount of viable myocardium present, the larger 
reverse remodeling. Speckle tracking imaging, 
which is an angle independent approach to strain 
analysis, has enabled the development of new 
parameters to assess both global and segmental 
function [15]. Longitudinal mechanics reflect the 
function of longitudinally aligned fibers within the 
subendocardium, the most sensitive layer to the 
presence of myocardial disease. After evaluating 
90 patients with chronic ischemic LV dysfunc-
tion, Roes et al. [16] demonstrated that global and 
regional LS measured with speckle tracking was 
associated with the global and regional extent of 
scar tissue on CMR. After analyzing 1,077 ischemic 
and non-ischemic patients implanted with CRT, 
MADIT-CRT trial found that dyssynchrony and 
global LS were independent factors predicting CRT 
response and the benefit from CRT was greatest 
in patients with greater baseline contractile func-
tion (global LS ≤ –8.7%) [17]. In the present study, 
we also found that global LS was related to CRT 
response.
Shen et al. [18] generated a 7-point patient 
selection score system based on RV pacing-induced 
left bundle branch block, use of beta-blockers, wall 
motion score index, left atrial volume index, clear-
ance of creatinine and LV dyssynchrony analyzed 
by tissue Doppler imaging combined with pulse-
wave Doppler, to predict CRT response. However, 
that system did not select the RV function as 
variable. RV ejection fraction was correlated well 
with LV function [19]. Impairment of RV systolic 
function has been consistently associated with 
worse outcomes in patients with advanced heart 
failure, independently of LV function [20]. Previous 
studies reported that RV dysfunction represented 
a strong predictor of lack of clinical response to CRT 
[21–23]. In the present study, we used TAPSE, 
a simple, less dependent on optimal image quality 
and reproducible method to assess RV function and 
found that TAPSE was a strong variable to predict 
CRT response.
The hazard ratio was influenced by the units 
of the variables in continuous data. That was the 
result why we used Wald value to evaluate the 
weight of the variables. Therefore, we assigned 
2 points to the variable reaching the highest Wald 
values and 1 point to other variables.
This selection score system, integrating elec-
trical dyssynchrony, myocardial contractile function 
and RV function, was a strong predictor of CRT 
response. A score > 2 was associated with a 6-fold 
increase in CRT response compared to a score ≤ 2. 
Table 6. Sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of 
score system to predict cardiac resynchronization therapy response.
Sensitivity Specificity PPV NPV
Score > 2 50/54 (92.59%) 28/39 (71.79%) 50/61(81.96%) 28/32 (87.50%)
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This score system might be helpful to target pa-
tients who could benefit from CRT implantation.
MADIT-CRT [24] trial observed that after CRT 
implanted for 1 year, LV dyssynchrony, which was 
determined as standard deviation of time to peak 
transverse strain, and contractile function, which 
was determined as global LS, improved to a great 
extent. We observed that after CRT implantation, 
inter and intraventricular dyssynchrony improved 
significantly. In CRT responders, LV global longitu-
dinal improved gradually after CRT implantation and 
reached statistical significance at the end of follow-
-up. One of the key mechanisms of CRT was to cor-
rect mechanical dyssynchrony within the LV and to 
recruit “wasted work” of dyssynchronous segments 
toward cardiac output, whose hemodynamic benefit 
could been observed immediately after activating 
biventricular pacing [25]. After long-term CRT, ion 
channel remodeling and abnormal Ca2+ homeostasis 
was restored, contributing to beneficial reverse re-
modeling and improvement of contractile function 
[26]. This could partly explain the results of the 
present study that inter and intraventricular dys-
synchrony was greatly improved at the early stage 
of follow-up, while strain values increased gradually.
Limitations of the study
This study included a relatively small number of 
patients. Not including patients with atrial fibrillation, 
our results should only be applied to patients with 
sinus rhythm. Furthermore, this score system has 
not been tested prospectively to determine its use in 
a large number of patients receiving CRT. Prospec-
tive studies with large number of patients, longer 
periods of follow-up with hard clinical endpoints will 
be necessary to determine the clinical significance of 
our findings in predicting CRT response.
Conclusions
A patient selection score system based on the 
integration of TAPSE, LS and CLBBB combined 
with a wide QRSd could help to predict positive 
response to CRT effectively and reliably.
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